Kontermann RE - Search Results

1

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma.

Krishna Moorthy N, Seifert O, Eisler S, Weirich S, Kontermann RE, Rehm M, Fullstone G. Krishna Moorthy N, et al. Among authors: kontermann re. Molecules. 2021 Dec 14;26(24):7582. doi: 10.3390/molecules26247582. Molecules. 2021. PMID: 34946664 Free PMC article.

2

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity.

Siegemund M, Pollak N, Seifert O, Wahl K, Hanak K, Vogel A, Nussler AK, Göttsch D, Münkel S, Bantel H, Kontermann RE, Pfizenmaier K. Siegemund M, et al. Among authors: kontermann re. Cell Death Dis. 2012 Apr 12;3(4):e295. doi: 10.1038/cddis.2012.29. Cell Death Dis. 2012. PMID: 22495350 Free PMC article.

3

The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.

Seifert O, Plappert A, Heidel N, Fellermeier S, Messerschmidt SK, Richter F, Kontermann RE. Seifert O, et al. Among authors: kontermann re. Protein Eng Des Sel. 2012 Oct;25(10):603-12. doi: 10.1093/protein/gzs059. Epub 2012 Sep 17. Protein Eng Des Sel. 2012. PMID: 22988132

4

Tetravalent antibody-scTRAIL fusion proteins with improved properties.

Seifert O, Plappert A, Fellermeier S, Siegemund M, Pfizenmaier K, Kontermann RE. Seifert O, et al. Among authors: kontermann re. Mol Cancer Ther. 2014 Jan;13(1):101-11. doi: 10.1158/1535-7163.MCT-13-0396. Epub 2013 Oct 3. Mol Cancer Ther. 2014. PMID: 24092811

5

Expression and purification of recombinant antibody formats and antibody fusion proteins.

Siegemund M, Richter F, Seifert O, Unverdorben F, Kontermann RE. Siegemund M, et al. Among authors: kontermann re. Methods Mol Biol. 2014;1131:273-95. doi: 10.1007/978-1-62703-992-5_18. Methods Mol Biol. 2014. PMID: 24515473

6

Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticles.

Seifert O, Pollak N, Nusser A, Steiniger F, Rüger R, Pfizenmaier K, Kontermann RE. Seifert O, et al. Among authors: kontermann re. Bioconjug Chem. 2014 May 21;25(5):879-87. doi: 10.1021/bc400517j. Epub 2014 May 7. Bioconjug Chem. 2014. PMID: 24766622

7

Tailoring the stealth properties of biocompatible polysaccharide nanocontainers.

Kang B, Okwieka P, Schöttler S, Seifert O, Kontermann RE, Pfizenmaier K, Musyanovych A, Meyer R, Diken M, Sahin U, Mailänder V, Wurm FR, Landfester K. Kang B, et al. Among authors: kontermann re. Biomaterials. 2015 May;49:125-34. doi: 10.1016/j.biomaterials.2015.01.042. Epub 2015 Feb 16. Biomaterials. 2015. PMID: 25725561

8

Immunoliposomes for Targeted Delivery of an Antifibrotic Drug.

Schuster L, Seifert O, Vollmer S, Kontermann RE, Schlosshauer B, Hartmann H. Schuster L, et al. Among authors: kontermann re. Mol Pharm. 2015 Sep 8;12(9):3146-57. doi: 10.1021/acs.molpharmaceut.5b00012. Epub 2015 Jul 28. Mol Pharm. 2015. PMID: 26181293

9

A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties.

Unverdorben F, Hutt M, Seifert O, Kontermann RE. Unverdorben F, et al. Among authors: kontermann re. PLoS One. 2015 Oct 2;10(10):e0139838. doi: 10.1371/journal.pone.0139838. eCollection 2015. PLoS One. 2015. PMID: 26430884 Free PMC article.

10

Pharmacokinetic properties of IgG and various Fc fusion proteins in mice.

Unverdorben F, Richter F, Hutt M, Seifert O, Malinge P, Fischer N, Kontermann RE. Unverdorben F, et al. Among authors: kontermann re. MAbs. 2016;8(1):120-8. doi: 10.1080/19420862.2015.1113360. MAbs. 2016. PMID: 26514880 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page